Exosomes, the basic building blocks of cells, regulate biological processes such as tissue regeneration and disease resistance by providing communication between cells. Seltek Group’s patented HybrosomeTM Technology provides healing and regeneration at the cellular level by isolating exosomes and making them available in the long term. This technology revolutionizes areas such as anti-aging, skin regeneration, hair loss and wound healing by carrying the vitamins and minerals that cells need.
Morphiya HybrosomeTM technology is revolutionizing the health sector by offering significant potential in the treatment of different diseases. This innovative technology, developed under the leadership of Turkish scientists and physicians, including Assoc. Prof. Dr. Tunç Tiryaki, enables the emergence of new generation products in skin care and wound healing.
Seltek Group introduced this innovative product with the launch of “Morphiya HibrozomTM Technology” on May 16, 2024 at Hilton Bomonti Hotel. Seltek Group, which aims to contribute to Türkiye’s rising value in the field of medical aesthetics, will continue to reinforce its leading position in the sector.
